Sign Up | Log In | What is SocialPicks?

Medicis Pharmaceutical Corp. (MRX) Trade Now » Rate MRX - Discuss MRX - Add to Watch List

Sector: Healthcare > Industry: Biotechnology & Drugs

SocialPicks Sentiment:

** v.s. other stocks

This Quarter's Sentiment:

All:

100.0%

Top:

50.0%

Rate MRX:

Home

Analysis & Videos

Quotes

Bull or Bear

Discuss

MRX Analysis & Videos »

... View All >

MRX: Bull or Bear?

Medicis Reports Second Quarter 2009 Financial Results MRX

62%

+25.08%
in 96 days

Wednesday, August 05, 2009 4:05:54 PM ET

Medicis ( MRX ) today announced record net revenues of approximately $141.2 million for the three months ended June 30, 2009, compared to net revenues of approximately $137.4 million for the three months ended June 30, 2008, representing an increase of approximately 3%. This increase was due primarily to the strength of SOLODYN(R), and the launch of DYSPORT(TM) on June 15, 2009.

<> Non-generally accepted accounting principles (non-GAAP) earnings per diluted share (defined belo...

Continue reading »

By Marian Filo (-24.55% risk: aggressive) 08/06/09

Comment

... View All >

People Bullish on MRX

Marian Filo

Principal

62%

3 mos ago

Statistician

Analyst

N/A

11 mos ago

Art

Analyst

N/A

11 mos ago

palabok

Analyst

N/A

about 1 year ago

elsucka

Analyst

18%

about 1 year ago

People Bearish on MRX

... View All >

ROCK-STAR INVESTORS

Rank	Name	Sharpe Ratio	Avg Return	Followers
1	noshoes	21.10	+34.56%	369
2	Gerald Greene	18.14	+69.43%	206
3	stockmarketfunding.com	17.66	+25.71%	53
4	akiralegrand	13.47	+14.32%	61
5	anup2104	12.13	+75.75%	34

... more »

POPULAR STOCKS

Symbol	Company Name	Sentiment
MSFT	Microsoft Corp
POT	Potash Corp. of Saskatchewan Inc.
GS	Goldman Sachs Group Inc The
GM	General Motors Corp
BA	The Boeing Company
FNM	Fannie Mae

... more »

TODAY'S HEADLINES

LDK Solar's Growth Potential Offset by Gross Margin Pressure
by Paul Cheung (Zacks.com) about LDK

Cisco Systems Still a Wait and See
by Thomas Catino (Ant & Sons) about CSCO

The Merrill Lynch Diet: Starving Shareholders
by Zack Miller (BloggingStocks) about MER

Until Housing Improves, Don't Expect Stocks to Rebound
by J.D. Steinhilber (Agile Investing) about SPY

Google Blows Q2: Multiple Compression to Continue
by Henry Blodget about GOOG

... more »

TODAY'S TOP PICKS

TTWO		Take Two on Take Two Interactive by jgarner3999
NPD		NPD - CHINA NEPSTAR POISED FOR SIGNIFICANT GROWTH by penny7
EXAS		EXACT Sciences (NASDAQ: EXAS): Buy and Hold for Long-Term Upside by Mike Havrilla
DNDN		New Global Equity Index to Track Immunotherapy, Vaccine Stocks by Mike Havrilla
BNI		Railroad Stocks Steam Ahead on Buffett’s Buy of BNI by Mike Havrilla

... more »

StreetInsider.com on MRX

Form 10-Q MEDICIS PHARMACEUTICAL For: Sep 30

Medicis to Present at Credit Suisse Annual Healthcare Conference

Medicis (MRX) Reports Q3 EPS of $0.50, Beats by 8c; Guides Q4

Form 8-K MEDICIS PHARMACEUTICAL For: Nov 04

Medicis Reports Third Quarter 2009 Financial Results

Discussion Wall

+ Add

amritadas (+0.00%)

A FREE report on upcoming FDA decision for small ca.. - FDA decision date coming up this month for small cap company's Pain drug. If the FDA approves the drug, the peak sales could reach over 200% of the com...

+	0 replies

... more »

More Resources

About Medicis Pharmaceutical Corp. - Answers.com

Historical Prices - Yahoo

Message Boards - BoardCentral.com

More Info: Yahoo | Google | Reuters

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.